Clinical Trial

Comparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic Cancer

Completed
View on ClinicalTrials.gov →
Summary
This trial aimed to determine whether neoadjuvant chemoradiotherapy improves overall survival compared with upfront surgery, both followed by adjuvant chemotherapy in patients with resectable and borderline resectable pancreatic cancer.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-10; most recent amendment 2026-07-09.
Status change: Recruiting → Completed 2026-05-21
Trial Details
NCT Number NCT06978322
Lead Sponsor Minia University
Conditions Surgery, Neoadjuvant Chemotherapy, Management, Resectable Pancreatic Cancer
Enrollment 50 participants
Start Date 2025-02-01
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-13